These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 26163537)

  • 41. Genetic testing for hereditary hyperparathyroidism and familial hypocalciuric hypercalcaemia in a large UK cohort.
    Mariathasan S; Andrews KA; Thompson E; Challis BG; Wilcox S; Pierce H; Hale J; Spiden S; Fuller G; Simpson HL; Fish B; Jani P; Seetho I; Armstrong R; Izatt L; Joshi M; Velusamy A; Park SM; Casey RT
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):409-418. PubMed ID: 32430905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Familial Hyperparathyroidism.
    Blau JE; Simonds WF
    Front Endocrinol (Lausanne); 2021; 12():623667. PubMed ID: 33716975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetics of Hyperparathyroidism, Including Parathyroid Cancer.
    Simonds WF
    Endocrinol Metab Clin North Am; 2017 Jun; 46(2):405-418. PubMed ID: 28476229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endocrine neoplasms in familial syndromes of hyperparathyroidism.
    Li Y; Simonds WF
    Endocr Relat Cancer; 2016 Jun; 23(6):R229-47. PubMed ID: 27207564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early-onset, severe, and recurrent primary hyperparathyroidism associated with a novel CDC73 mutation.
    Shibata Y; Yamazaki M; Takei M; Uchino S; Sakurai A; Komatsu M
    Endocr J; 2015; 62(7):627-32. PubMed ID: 25959515
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Update on genetic and clinical aspects of primary hyperparathyroidism.
    Miedlich S; Krohn K; Paschke R
    Clin Endocrinol (Oxf); 2003 Nov; 59(5):539-54. PubMed ID: 14616876
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A hemodialysis patient with secondary hyperparathyroidism in whom primary parathyroid adenoma was resected 27 years previously].
    Itoh K; Tanaka M; Matsushita K; Tominaga Y
    Nihon Jinzo Gakkai Shi; 2003 Oct; 45(7):706-12. PubMed ID: 14631767
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Concomitant familial hypocalciuric hypercalcemia and single parathyroid adenoma: a case report.
    Marstrand SD; Tofteng CL; Jarløv A; Borgwardt L; Schwarz P
    J Med Case Rep; 2021 Sep; 15(1):471. PubMed ID: 34556169
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CDC73-related hereditary hyperparathyroidism: five new mutations and the clinical spectrum.
    Frank-Raue K; Haag C; Schulze E; Keuser R; Raue F; Dralle H; Lorenz K
    Eur J Endocrinol; 2011 Sep; 165(3):477-83. PubMed ID: 21652691
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Parathyroid glands involvement in multiple endocrine neoplasia].
    Târcoveanu E; Niculescu D; Cotea E; Moldovanu R; Vasilescu A; Crumpei F; Zbranca E; Zugun F; Rusu V; Ferariu D
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(2):482-96. PubMed ID: 21495355
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Hyperparathyroidism-jaw tumor syndrome. A hereditary form of primary hyperparathyroidism with parathyroid carcinoma].
    Raue F; Haag Ch; Frank-Raue K
    Dtsch Med Wochenschr; 2007 Jul; 132(27):1459-62. PubMed ID: 17583828
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Surgical therapy concept in primary hyperparathyroidism].
    Rusterholz D; Müller W
    Schweiz Med Wochenschr Suppl; 2000; 116():62S-65S. PubMed ID: 10780075
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recurrent or persistent hyperparathyroidism.
    Wells SA; Debenedetti MK; Doherty GM
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N158-62. PubMed ID: 12412795
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism.
    Bricaire L; Odou MF; Cardot-Bauters C; Delemer B; North MO; Salenave S; Vezzosi D; Kuhn JM; Murat A; Caron P; Sadoul JL; Silve C; Chanson P; Barlier A; Clauser E; Porchet N; Groussin L;
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E403-8. PubMed ID: 23293331
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overview of the 2022 WHO Classification of Parathyroid Tumors.
    Erickson LA; Mete O; Juhlin CC; Perren A; Gill AJ
    Endocr Pathol; 2022 Mar; 33(1):64-89. PubMed ID: 35175514
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular pathology of parathyroid tumors.
    Carling T
    Trends Endocrinol Metab; 2001 Mar; 12(2):53-8. PubMed ID: 11167122
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Parathyroid cancer: An update.
    Rodrigo JP; Hernandez-Prera JC; Randolph GW; Zafereo ME; Hartl DM; Silver CE; Suárez C; Owen RP; Bradford CR; Mäkitie AA; Shaha AR; Bishop JA; Rinaldo A; Ferlito A
    Cancer Treat Rev; 2020 Jun; 86():102012. PubMed ID: 32247225
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Loss of parafibromin expression in a subset of parathyroid adenomas.
    Juhlin C; Larsson C; Yakoleva T; Leibiger I; Leibiger B; Alimov A; Weber G; Höög A; Villablanca A
    Endocr Relat Cancer; 2006 Jun; 13(2):509-23. PubMed ID: 16728578
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidism.
    Frank-Raue K; Leidig-Bruckner G; Haag C; Schulze E; Lorenz A; Schmitz-Winnenthal H; Raue F
    Clin Endocrinol (Oxf); 2011 Jul; 75(1):50-5. PubMed ID: 21521328
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Parathyroid carcinoma].
    Krysiak R; Okopień B
    Pol Merkur Lekarski; 2007 Aug; 23(134):145-50. PubMed ID: 18044348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.